José Luis Ordoñez-Librado (2022) “L-DOPA/Capsazepine or L-DOPA/Rimonabant Co-Administration in an Experimental Parkinson Disease Model: Behavioral and Cellular Consequences”, Issues and Developments in Medicine and Medical Research Vol. 5, pp. 35–60. doi: 10.9734/bpi/idmmr/v5/2361C.